Subscriber Content Read Preview
Charred bits of plastic shrink wrap have been found in vials of Merck & Co. vaccines, Merck said, in the latest problem with quality at the company's biggest vaccine-making plant and one the company is still working to resolve.
Subscriber Content Read Preview
Bristol-Myers Squibb reported a slight decline in second-quarter earnings on restructuring charges, while revenue rose 14% on higher sales of top drugs, including blood thinner Plavix.
Subscriber Content Read Preview
A J&J; unit is lowering the maximum daily amount it recommends for Extra-Strength Tylenol pills to a level that comes in just shy of the reduction sought by medical experts two years ago.
Subscriber Content Read Preview
Boston Scientific reported a 49% climb in second-quarter earnings amid better-than-expected sales, despite continued tough conditions in the U.S. defibrillator market.
Subscriber Content Read Preview
Bayer reported a 41% rise in second-quarter net profit, boosted by strong sales of its crop-protection products, but said weakening demand in North America and Asia slowed volume sales at its plastics and foam unit MaterialScience.
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
Subscriber Content Read Preview
View an interactive map that shows you how stocks in the Pharmaceuticals & Biotech sector are doing today, at a glance.
Get in-depth research on Pharmaceuticals & Biotech companies, including complete news and financials, earnings estimates and more.
Ask a question about anything you choose, and let readers from the Journal Community answer it.
Hello
Your question to the Journal Community Your comments on articles will show your real name and not a username.Why?
Create a Journal Community profile to avoid this message in the future. (As a member you agree to use your real name when participating in the Journal Community)